Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

SHA:600436 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	9,748	10,756	10,036	8,674	8,004	6,493
Other Revenue	31.87	31.87	22.31	19.52	17.29	18.28
Revenue	9,780	10,788	10,058	8,694	8,022	6,511
Revenue Growth (YoY)	-10.35%	7.25%	15.70%	8.38%	23.20%	13.78%
Cost of Revenue	6,124	6,189	5,363	4,735	3,968	3,584
Gross Profit	3,656	4,599	4,695	3,959	4,054	2,926
Selling, General & Admin	845.21	858.09	1,150	814.41	1,027	982.2
Research & Development	304.97	269.59	232.35	230.03	199.51	97.55
Other Operating Expenses	26.95	48.19	70.77	71.96	72.05	53.23
Operating Expenses	1,184	1,179	1,465	1,110	1,306	1,135
Operating Income	2,472	3,420	3,230	2,849	2,748	1,792
Interest Expense	-31.29	-37.62	-37.31	-38.01	-32.9	-27.39
Interest & Investment Income	424.23	182.59	170.81	171.62	144.48	149.27
Currency Exchange Gain (Loss)	7.57	7.57	3.09	7.18	-3.28	-3.27
Other Non Operating Income (Expenses)	-14.33	-3.03	6.02	-36.47	-21.62	-4.4
EBT Excluding Unusual Items	2,858	3,569	3,373	2,954	2,834	1,906
Gain (Loss) on Sale of Investments	-1.51	-8.95	8.32	-0.02	4.54	6.72
Gain (Loss) on Sale of Assets	3.99	3.87	0.96	11.14	27.59	40.29
Asset Writedown	1	-	-	-0.33	-1.02	-
Other Unusual Items	-25.54	-25.54	-13.06	13.18	3.55	26.08
Pretax Income	2,836	3,539	3,369	2,978	2,869	1,979
Income Tax Expense	424.7	543.21	517.77	454.76	404.23	289.54
Earnings From Continuing Operations	2,411	2,996	2,851	2,523	2,465	1,689
Minority Interest in Earnings	8.59	-18.52	-53.79	-50.63	-32.9	-17.84
Net Income	2,420	2,977	2,797	2,472	2,432	1,672
Net Income to Common	2,420	2,977	2,797	2,472	2,432	1,672
Net Income Growth	-21.42%	6.42%	13.15%	1.66%	45.49%	21.62%
Shares Outstanding (Basic)	603	604	603	603	603	603
Shares Outstanding (Diluted)	603	604	603	603	603	603
Shares Change (YoY)	-0.04%	0.16%	-0.02%	-0.07%	0.00%	0.11%
EPS (Basic)	4.01	4.93	4.64	4.10	4.03	2.77
EPS (Diluted)	4.01	4.93	4.64	4.10	4.03	2.77
EPS Growth	-21.39%	6.25%	13.17%	1.74%	45.49%	21.49%
Free Cash Flow	-704.71	245.41	2,065	6,698	370.11	1,048
Free Cash Flow Per Share	-1.17	0.41	3.42	11.11	0.61	1.74
Dividend Per Share	1.820	2.970	2.320	1.250	1.210	0.900
Dividend Growth	-47.55%	28.02%	85.60%	3.31%	34.44%	9.76%
Gross Margin	37.38%	42.63%	46.68%	45.54%	50.53%	44.95%
Operating Margin	25.27%	31.70%	32.11%	32.77%	34.25%	27.52%
Profit Margin	24.74%	27.60%	27.81%	28.44%	30.32%	25.67%
Free Cash Flow Margin	-7.21%	2.27%	20.53%	77.04%	4.61%	16.10%
EBITDA	2,517	3,475	3,298	2,897	2,854	1,882
EBITDA Margin	25.74%	32.21%	32.79%	33.32%	35.58%	28.90%
D&A For EBITDA	45.39	55	67.82	47.36	106.25	90.21
EBIT	2,472	3,420	3,230	2,849	2,748	1,792
EBIT Margin	25.27%	31.70%	32.11%	32.77%	34.25%	27.52%
Effective Tax Rate	14.98%	15.35%	15.37%	15.27%	14.09%	14.63%
Revenue as Reported	9,780	10,788	10,058	8,694	8,022	6,511
Advertising Expenses	-	258.62	531.48	255.04	445	473.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.